Voyageur Pharmaceuticals Ltd (VM : TSX-V)
Common Stock
Follow VM
VM
Voyageur Pharmaceuticals Ltd
WealthAwesomePerformance
1 Day
+12.50%
1 Week
+8.00%
1 Month
+3.85%
YTD
-20.59%
The Saturday TSX Wrap · free, every saturday morning. The week on the TSX, in five minutes.
Key Statistics
Market Cap
$27.31M
52W High
$0.20
52W Low
$0.07
P/E Ratio
-
50 Day MA
$0.14
200 Day MA
$0.13
Beta
0.46
Dividend Yield
-
Performance history
VM returns since 2023
Voyageur Pharmaceuticals Ltd has traded since Nov 2023 in our data, with 2 up years out of 2 full calendar years. Its deepest fall was −76.5% (Jun 2025 to May 2026).
1 year / yr
−15.6%
3 years / yr
+44.2%
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2023*+66.7%
- 2024+13.3%
- 2025+100.0%
- 2026*−20.6%
* Partial year (first year of data, or year to date).
$10,000 invested in VM
- 1 year ago$8,438
- 2023 (start of our data)$30,000
- Best year
- 2025: +100.0%
- Worst year
- 2024: +13.3%
- All-time high in our data
- $0 on Jun 27, 2025 · now −60.3%
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Nov 2023 to Nov 2026. Past returns do not predict future ones.
Awesome Portfolio™
Looking past VM? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/9/2026 | $0.13 | $0.14 | $0.13 | $0.14 | $0.14 | 183,860 |
| 11/6/2026 | $0.12 | $0.13 | $0.12 | $0.12 | $0.12 | 62,106 |
| 11/5/2026 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 57,175 |
| 11/4/2026 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 12,524 |
| 11/3/2026 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 5,500 |
| 11/2/2026 | $0.13 | $0.13 | $0.13 | $0.13 | $0.13 | 38,040 |
| 10/30/2026 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 21,501 |
| 10/29/2026 | $0.13 | $0.13 | $0.12 | $0.12 | $0.12 | 108,580 |
| 10/28/2026 | $0.14 | $0.14 | $0.12 | $0.12 | $0.12 | 147,500 |
| 10/27/2026 | $0.12 | $0.14 | $0.12 | $0.14 | $0.14 | 175,500 |
Analyst Price Targets
Based on analyst covering VM · as of Sep 17, 2026
Wall Street analysts forecast VM stock price to rise 307.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.55
+307.4% Upside
Current Price
C$0.14
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on VM's historical volatility
30-Day Vol
106.2%
Annualized
90-Day Vol
78.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.11
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.13 | C$0.09 – C$0.18 |
| 60 trading days | C$0.12 | C$0.07 – C$0.20 |
| 90 trading days | C$0.11 | C$0.06 – C$0.21 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Voyageur Pharmaceuticals Ltd
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. The company has a collaboration with Bayer for the research and development of evaluating potential future production of iodine to be used in contrast media drugs. Voyageur Pharmaceuticals Ltd. was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. The company is headquartered in Calgary, Canada.
Financials
- Revenue (TTM)
- $50,854
- EBITDA
- $-2.60M
- Profit Margin
- 0.00%
- ROE (TTM)
- -111.54%
- EPS (Diluted)
- -0.02
- Book Value
- 0.02
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Free newsletter
The Saturday TSX Wrap
The week on the TSX, in five minutes
- The biggest gainers and losers, and why they moved
- Sector and momentum moves at a glance
- The Canadian market stories you missed
Explore More
Common Questions About VM
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.